Lakefront Biotherapeutics NV 20-F for FY2024
Lakefront Biotherapeutics NV (LKFT)
20-F
2025-03-27
For: 2024-12-31
View Original
Added on
April 04, 2026
About this 20-F
Lakefront Biotherapeutics NV filed this 20-F on March 27, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 275.65M EUR
- up 15.0% from 239.72M EUR a year earlier
- Net income
- 74.08M EUR
- down 65.0% from net income of 211.7M EUR a year earlier
- Diluted EPS
- 1.12 EUR
- down 65.1% from 3.21 EUR a year earlier